Robert Hess
About Robert Hess
Robert Hess is a board member, angel investor, and patent attorney with a focus on pharmaceuticals, medtech, and B2B SaaS. He is a member of several angel groups and serves as co-chair of the Digital Health committee at Life Science Angels.
Robert Hess - Board Member and Angel Investor
Robert Hess currently serves as a board member. He is also an active angel investor with affiliations to multiple angel networks, including Life Science Angels (LSA), Band of Angels, and Tech Coast Angels. His investment focus encompasses pharmaceuticals, medtech, and B2B SaaS sectors. Additionally, he serves as the co-chair of the Digital Health committee at LSA, highlighting his active involvement in the intersection of healthcare and technology.
Robert Hess - Education and Expertise
Robert Hess holds a diverse and robust educational background. He earned a B.S. degree in Biochemistry from Cornell University, followed by a Ph.D. in Molecular Biophysics from the University of Wisconsin – Madison. He also holds a J.D. from Suffolk University Law School, equipping him with extensive knowledge in both the life sciences and legal fields. His expertise spans across patent law, pharmaceuticals, medtech, and B2B SaaS.
Robert Hess - Career as a Patent Attorney
Robert Hess has substantial experience as a patent attorney, having held both in-house and private practice positions. He has prosecuted patents primarily in the biotechnology and medical device industries. His career includes roles at Solazyme, Boston Biomedica, BioSeq, Sunstein Kann Murphy & Timbers, Biomarin Pharmaceutical, and Leydig, Voit & Mayer. His work has aided in the advancement and protection of various innovative technologies.
Robert Hess - Strategic Advisor in Pharmaceuticals and Medtech
As a strategic advisor, Robert Hess primarily focuses on pharmaceuticals, medtech, and B2B SaaS companies. His role involves providing expert guidance on market trends, regulatory affairs, and strategic business development. His extensive background in both science and law uniquely positions him to offer comprehensive advisory services to companies operating at the intersection of technology and healthcare.